Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
DOSAGE REGIMEN FOR ADMINISTERING A CD19XCD3 BISPECIFIC ANTIBODY
No-Receipt date
2021-01030 - 16/03/2021
No-Filing date
20210400715 - 16/03/2021
No-Granting date
3087221.B2 - 26/03/2021
No-EPO application date
10771102.0 - 27/10/2010
No-EPO granting date
2493503 - 20/01/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2021 - 16/04/2021
Expiration date
28/10/2030
Kind of title
Amended European Patent Validation
Legal status
VALID
Priorities
EP0917410427/10/2009/EP
US255290 P27/10/2009/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/00
C07K 16/28
G01N 33/50
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20150402144
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1284678
AMGEN RESEARCH (MUNICH) GMBH
STAFFELSEESTRASSE 2
81477 MUNCHEN
GERMANY
Inventors
Code
Firstname
Surname
3285172
NAGORSEN, DIRK
3285173
KUFER, PETER
3285174
ZUGMAIER, GERHARD
3285175
BAEUERLE, PATRICK
Representatives
Code
Firstname
Surname
Address
Town
Zip
3463
MARIA
ATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).